Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.3.1 to v3.3.2 on the Record History page, with no changes to study data or content. No significant content updates were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedIn the record history, the revision is updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding/operating-status disclaimer that warned about potential delays and directed users to cc.nih.gov and opm.gov.SummaryDifference0.4%

- Check35 days agoChange DetectedA new version dated 2023-06-27 updates multiple core sections including Study Status, Study Description, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations, Document Section, and IPD Sharing.SummaryDifference0.1%

- Check64 days agoChange DetectedPage now includes an official operating-status notice and updates version to v3.2.0, replacing v3.1.0.SummaryDifference9%

- Check71 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.